课题基金 / 基金详情

Cross sectional and longitudinal measures of quality of life and utility among patients with chronic hepatitis C virus infection

Cross sectional and longitudinal measures of quality of life and utility among patients with chronic hepatitis C virus infection
慢性丙型肝炎病毒感染患者生活质量和效用的横断面和纵向测量
批准号：
310025
负责人：
Wong William Wai Lun
金额：
$0.0万
依托单位：
University of Toronto
依托单位国家：
加拿大
项目类别：
Operating Grants
财政年份：
2014
资助国家：
加拿大
项目状态：
已结题
起止时间：
2014-03-01 至 2015-03-01
来源：
https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=310025&lang=en
关键词：
Cost-Effectivenss Direct-Acting Antiviral Therapies Hepatitis C Out-Of-Pocket Costs Preferences Quality Of Life Time Costs Utility

项目摘要

项目成果

Wong William Wai Lun的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
There are 70,000 patients with chronic hepatitis C (CHC) infection in Canada who have not been treated, even though effective treatment is available. In this study, we plan to measure the quality of life and economic burden of CHC infection. The quality o
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Towards establishing accurate estimates of national chronic hepatitis B prevalence and undiagnosed proportion in Canada
  • 批准号：
    488763
  • 项目类别：
    Operating Grants
  • 资助金额：
    $7.29万
  • 财政年份：
    2023
  • 负责人：
    Wong William Wai Lun
  • 依托单位：
    University of Waterloo (Ontario)
Developing policy models for sexually transmitted and blood-borne infection: integrating best evidence of effectiveness, safety, cost, and patient preferences
  • 批准号：
    499040
  • 项目类别：
    Salary Programs
  • 资助金额：
    $83.78万
  • 财政年份：
    2023
  • 负责人：
    Wong William Wai Lun
  • 依托单位：
    University of Waterloo (Ontario)
Evaluating the impact of direct-acting antiviral treatment access policy on chronic hepatitis C prevalence and the undiagnosed proportion
  • 批准号：
    475136
  • 项目类别：
    Operating Grants
  • 资助金额：
    $10.93万
  • 财政年份：
    2022
  • 负责人：
    Wong William Wai Lun
  • 依托单位：
    University of Waterloo (Ontario)
Improvements in quality of life, health utility, cost, and return to work for lymphoma patients after chimeric antigen receptor T- cells therapy in a real-world setting
  • 批准号：
    456739
  • 项目类别：
    Operating Grants
  • 资助金额：
    $7.29万
  • 财政年份：
    2021
  • 负责人：
    Wong William Wai Lun
  • 依托单位：
    University of Waterloo (Ontario)
海外基金